Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6288802 | 0.97 | CYP3A4 (0.34) | CYP3A4MAPK1MAPTGABRA2GABRB2 | |
| SCHEMBL217662 | 0.89 | CYP3A4 (0.34) | CYP3A4MAPK1MAPTGABRA2GABRB2 | |
| SCHEMBL1481145 | 0.86 | GPBAR1 (0.33) | — | |
| SCHEMBL6053995 | 0.86 | GABRA2 (0.33) | GABRA2GABRB2RIPK1 | |
| SCHEMBL6054088 | 0.85 | GABRA2 (0.32) | GABRA2GABRB2 | |
| SCHEMBL6054015 | 0.85 | GABRA2 (0.32) | GABRA2GABRB2 | |
| SCHEMBL6053928 | 0.85 | GABRA2 (0.32) | GABRA2GABRB2 | |
| SCHEMBL6054044 | 0.85 | GABRA2 (0.32) | GABRA2GABRB2 | |
| SCHEMBL140047 | 0.83 | LMNA (0.38) | CYP3A4MAPK1TSHRPDE2AIDO1 | |
| SCHEMBL628169 | 0.82 | GABRA2 (0.36) | CYP3A4MAPK1MAPTGABRA2GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1828 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114867758-B | Metallocene and method thereof | 埃克森美孚化学专利公司 | 2025-04-08 | — | — | CN | claimed |
| CN-113614123-B | Transition metal bis (phenoxide) complexes and their use as olefin polymerization catalysts | 埃克森美孚化学专利公司 | 2024-01-23 | — | — | CN | claimed |
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-09-19 | — | — | US | claimed |
| EP-4222180-A1 | BIS(HETEROCYCLIC-OLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-08-09 | — | — | EP | claimed |
| CN-116490528-A | Polymer compositions containing cyclics obtained using transition metal bis (phenoxide) catalyst complexes and process for their preparation | 埃克森美孚化学专利公司 | 2023-07-25 | — | — | CN | claimed |
| CN-116323694-A | Bis (heterocyclic-alkoxide) lewis base catalysts and methods thereof | 埃克森美孚化学专利公司 | 2023-06-23 | — | — | CN | claimed |
| EP-4196507-A1 | CYCLIC CONTAINING POLYMER COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-06-21 | — | — | EP | claimed |
| CN-113423742-B | Bis (arylphenoxide) lewis base catalysts and methods thereof | 埃克森美孚化学专利公司 | 2023-05-05 | — | — | CN | claimed |
| CN-113423744-B | Lewis base catalyst and method thereof | 埃克森美孚化学专利公司 | 2023-05-05 | — | — | CN | claimed |
| EP-4103629-A1 | POLYETHYLENE COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| WO-2005068519-A2 | CATALYST COMPOSITIONS AND POLYOLEFINS FOR EXTRUSION COATING APPLICATIONS | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2005-07-28 | — | — | WO | claimed |
| US-20050159300-A1 | Dual metallocene catalyst for producing film resins with good machine direction (MD) elmendorf tear strength | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2005-07-21 | — | — | US | claimed |
| US-20050153830-A1 | contact product of a first metallocene compound, a second metallocene compound, a chemically-treated solid oxide, and an organoaluminum compound; useful properties in impact, tear, adhesion, sealing, extruder motor loads and pressures at comparable melt index values, and neck-in and draw-down. | CHEVRON PHILIPS CHEMICAL COMPANY LP | 2005-07-14 | — | — | US | claimed |
| WO-2005052011-A1 | CATALYST COMPOSITIONS FOR PRODUCING POLYOLEFINS IN THE ABSENCE OF COCATALYSTS | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2005-06-09 | — | — | WO | claimed |
| US-20050119514-A1 | Oligomerization of olefins comprising at least three carbon atoms | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-02 | — | — | US | claimed |
| US-20050113245-A1 | STANNOXY-SUBSTITUTED METALLOCENE CATALYSTS FOR OLEFIN AND ACETYLENE POLYMERIZATION | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2005-05-26 | — | — | US | claimed |
| US-20050113243-A1 | Catalyst compositions for producing polyolefins in the absence of cocatalysts | CHEVRON PHILLIPS CHEMICAL COMPANY, LP | 2005-05-26 | — | — | US | claimed |
| US-20040266961-A1 | Catalyst composition II | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-30 | — | — | US | claimed |
| WO-2004106390-A2 | POLYMERIZATION AND OLIGOMERIZATION CATALYST WITH TRIDENTATE OR TETRADENTATE LIGAND | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-12-09 | — | — | WO | claimed |
| US-20040122191-A1 | Supercritical polymerization process and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC | 2004-06-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | ODC1, DDT, OXGR1 | CYP3A4 803/4885MAPK1 2002/4885MAPT 4240/4885 |
| US-20040266961-A1 | Catalyst composition II | MLX, CBX2, BMX | CYP3A4 2959/4885MAPK1 4372/4885MAPT 1902/4885 |
| US-20050119514-A1 | Oligomerization of olefins comprising at least three carbon atoms | OXER1, OSBP, COG7 | CYP3A4 1276/4885MAPK1 2323/4885MAPT 2783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.